Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
06/24/2010 | US20100160225 Lefty, lefty derivatives and uses thereof |
06/24/2010 | US20100160216 Enhanced transport using membrane disruptive agents |
06/24/2010 | US20100160209 Composition and Method for Increasing Cell Permeability of a Compound |
06/24/2010 | US20100159032 Combinations useful for the treatment of neuronal disorders |
06/24/2010 | US20100159005 COMBINATION OF TRIAZINE DERIVATIVES AND PPARalpha AGONISTS |
06/24/2010 | US20100158999 Combination of triazine derivatives and hmg-coa reductase inhibitors |
06/24/2010 | US20100158998 Formulations comprising vitamin d or derivatives thereof |
06/24/2010 | US20100158996 Ester compound and medical use thereof |
06/24/2010 | US20100158995 Systems for delivery and release of angiotensin-(1-7) |
06/24/2010 | US20100158973 Therapeutic uses of cannabidiol compounds |
06/24/2010 | US20100158958 Gastric reflux resistant dosage forms |
06/24/2010 | US20100158956 Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement |
06/24/2010 | US20100158918 Polypeptides and polynucleotides encoding same |
06/24/2010 | US20100158914 Klotho beta |
06/24/2010 | US20100158888 Use of alkaline phosphatase to maintain healthy tissue mass in mammals |
06/24/2010 | US20100158843 Novel 3-phenylpropanoic compound activators of receptors of ppar type and pharmaceutical/cosmetic compositions comprised thereof |
06/24/2010 | CA2756091A1 A microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type 1 diabetes mellitus |
06/24/2010 | CA2747715A1 Thiazolopyridine sirtuin modulating compounds |
06/24/2010 | CA2747306A1 1,3,4-oxadiazole derivatives and their uses to treat diabetes |
06/24/2010 | CA2745459A1 Thiazoles as cannabinoid receptor ligands |
06/23/2010 | EP2199295A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome |
06/23/2010 | EP2199284A1 Pharmaceutical composition for inhibiting accumulation of amyloid- beta protein |
06/23/2010 | EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors |
06/23/2010 | EP2197875A1 Diacylglycerol acyltransferase inhibitors |
06/23/2010 | EP2197873A1 Compounds and compositions as modulators of gpr119 activity |
06/23/2010 | EP2197858A2 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same |
06/23/2010 | EP2197849A1 N- ( pyrazole- 3 -yl) -benzamide derivatives as glucokinase activators |
06/23/2010 | EP2197846A1 Substituted 6-pheylnicotinic acids and the use thereof |
06/23/2010 | EP2197845A1 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof |
06/23/2010 | EP2197835A1 Bicyclic aryl and heteroaryl receptor modulators |
06/23/2010 | EP2197495A2 Lipopeptides for delivery of nucleic acids |
06/23/2010 | EP2197477A2 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s) |
06/23/2010 | EP2197470A2 Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections |
06/23/2010 | EP2197466A2 Use of retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections |
06/23/2010 | EP2197462A2 Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent |
06/23/2010 | EP2197437A1 Use of oleocanthal for the treatment of lipid metabolism disorders |
06/23/2010 | EP2197432A1 Use of diazoxide for suppressing the plasma insulin level in a mammal |
06/23/2010 | CN201510537U Rosuvastatin acid double-release capsule |
06/23/2010 | CN1906173B Protein modifier production inhibitor |
06/23/2010 | CN1759834B Application of berberine or associated with Simvastatin in preparing product for preventing or curing disease or symptom related to blood fat |
06/23/2010 | CN1468108B Bone health compositions derived from milk |
06/23/2010 | CN101754972A Crystal structures of SGLT2 inhibitors and processes for preparing same |
06/23/2010 | CN101754962A N-azacyclic substituted pyrrole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 for the treatment of diabetes and metabolic disorders |
06/23/2010 | CN101754961A Pyrimidinone derivatives and methods of use thereof |
06/23/2010 | CN101754954A Nitrogen-containing heterocyclic derivative having 11 ss-hydroxysteroid dehydrogenase type I inhibitory activity |
06/23/2010 | CN101748179A Preparation method of feather protein peptide |
06/23/2010 | CN101748028A Lipid-lowering and healthcare liquor |
06/23/2010 | CN101747426A Method for synthesizing pramlintide |
06/23/2010 | CN101747405A Berberine glycyrrhizic acid enantiomer salt and preparation method and usage thereof |
06/23/2010 | CN101747305A Five crystal forms of nicousamide compound and preparation method, pharmaceutical composition and usage thereof |
06/23/2010 | CN101747271A Method for preparing polysubstituted isoquinoline compounds |
06/23/2010 | CN101745116A Preparation method for copper ion chelate adsorbing medium used for curing Wilson's disease) |
06/23/2010 | CN101745112A Treatment of TNFalpha related disorders |
06/23/2010 | CN101745100A Buccal insulin dropping pill and preparation method thereof |
06/23/2010 | CN101745099A High-voltage electrostatic bur bract electric field foot patch for diabetes |
06/23/2010 | CN101745094A Medical application of MyD88 topological peptide compounds used as immunosuppressant |
06/23/2010 | CN101745048A Medicine for treating type II diabetes and resisting aging |
06/23/2010 | CN101745039A Chinese medicinal preparation for treating diabetes |
06/23/2010 | CN101745032A Traditional Chinese medicine composition for reducing blood fat and blood pressure |
06/23/2010 | CN101745028A Drug for treatment of diabetes and complications thereof and preparation method thereof |
06/23/2010 | CN101745027A Preparation method of xiaokeling condensed pill |
06/23/2010 | CN101745023A Compound bee product and preparation method thereof |
06/23/2010 | CN101745022A Chinese pharmaceutical composition for treatment of diabetes and preparation method thereof |
06/23/2010 | CN101745019A Chinese medicine formula for preventing and treating diabetic acromelic gangrene and application thereof |
06/23/2010 | CN101745018A Chinese medicine preparation for preventing and treating diabetic retinopathy and application thereof |
06/23/2010 | CN101744978A Drug compound for preventing and curing diabetes mellitus |
06/23/2010 | CN101744970A Medicine used for type 2 diabetes and preparation method thereof |
06/23/2010 | CN101744938A Pharmaceutical composition and preparation method thereof |
06/23/2010 | CN101744928A Method for extracting active substance in longan seeds |
06/23/2010 | CN101744912A Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
06/23/2010 | CN101744907A Applications of Chinese medicinal composition to preparation of medicament for treating hyperlipemia with hepatic lesion |
06/23/2010 | CN101744888A Cyclocarya paliurus leaf composition |
06/23/2010 | CN101744869A Compound traditional Chinese medicine extract composition for preventing and treating diabetes |
06/23/2010 | CN101744867A Soft capsules for treating apoplexy and preparation method thereof |
06/23/2010 | CN101744850A Preparation and application of total flavone extracted from plants, as well as pharmaceutical preparations thereof |
06/23/2010 | CN101744847A Agaricus compound polysaccharide capsule preparation method |
06/23/2010 | CN101744846A Edible mycotic composite amylase nutritional agent |
06/23/2010 | CN101744844A Fulvic acid or sodium fulvate substance with hypoglycemic function |
06/23/2010 | CN101744842A Lipidosome Chinese traditional medicine membranous plaster |
06/23/2010 | CN101744835A Tungstenic compound nutriment for preventing and treating calculus and gout class diseases of urinary system |
06/23/2010 | CN101744834A Compound fructose electrolyte injection and preparation method and application thereof |
06/23/2010 | CN101744790A Method for preparing stable-type vitamin A microcapsules continuously |
06/23/2010 | CN101744784A Double-layer slow-release tablet with puerarin derivatives and preparation method thereof |
06/23/2010 | CN101744781A Gliclazide dispersible tablets and preparation method thereof |
06/23/2010 | CN101744254A Weight reducing tea drink for women and preparation method thereof |
06/23/2010 | CN101744228A Preparation method of organic biological active iodine from brown algae and application thereof |
06/23/2010 | CN101744076A Method for making weight-losing longan tea |
06/23/2010 | CN101385719B Osmotic pump preparation composition for treating hyperlipemia |
06/23/2010 | CN101264203B Chinese and western medicine composition for treating diabetes |
06/23/2010 | CN101156862B A lecithin vitamine E mastication piece and method for making same |
06/23/2010 | CN101053582B Method for applying complete puncturevine herb in preparing medicine for treating insulin resisting hyperglycemia and hypertension |
06/23/2010 | CN101039908B Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
06/23/2010 | CN101019895B Health product for reducing blood sugar and its prepn |
06/23/2010 | CN101011091B Fermented tea, extract of fermented tea, composition for inhibiting elevation of blood sugar value, and beverage and foodstuff |
06/22/2010 | USRE41390 Trace elements |
06/22/2010 | US7741482 Reference standard for characterization of rosuvastatin |
06/22/2010 | US7741372 Targeting p38 mitogen activated protein kinase (MAPK) cellular signaling pathway; using such as N,N'-bis(3,5-diacetylphenyl)decanediamide tetrakis(amidinohydrazone) tetrahydrochloride |
06/22/2010 | US7741349 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer' |
06/22/2010 | US7741343 6H-oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
06/22/2010 | US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |